UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeted Therapy and Immunotherapy for Melanoma in Japan

Current treatment options in oncology, 2019-01, Vol.20 (1), p.7-13, Article 7

2019

Volltextzugriff (PDF)

Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma

The Journal of clinical investigation, 2019-09, Vol.129 (9), p.3827-3832

2019

Volltextzugriff (PDF)

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

The New England journal of medicine, 2017-11, Vol.377 (19), p.1824-1835

2017

Volltextzugriff (PDF)

Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab

Cancer science, 2018-11, Vol.109 (11), p.3583-3590

2018

Volltextzugriff (PDF)

The Development of a Skin Cancer Classification System for Pigmented Skin Lesions Using Deep Learning

Biomolecules (Basel, Switzerland), 2020-07, Vol.10 (8), p.1123

2020

Volltextzugriff (PDF)

Merkel cell carcinoma: a review of clinical management with focus on Asian patients

Japanese journal of clinical oncology, 2023-07, Vol.53 (8), p.673-679

2023

Volltextzugriff (PDF)

A review of the AJCC melanoma staging system in the TNM classification (eighth edition)

Japanese journal of clinical oncology, 2021-05, Vol.51 (5), p.671-674

2021

Volltextzugriff (PDF)

Epidemiology of skin cancer based on Japan's National Cancer Registry 2016–2017

Cancer science, 2023-07, Vol.114 (7), p.2986-2992

2023

Volltextzugriff (PDF)

Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice

Cancer science, 2022-12, Vol.113 (12), p.4300-4310

2022

Volltextzugriff (PDF)

Prognostic factor analysis of definitive radiotherapy using intensity-modulated radiation therapy and volumetric modulated arc therapy with boluses for scalp angiosarcomas

Scientific reports, 2022-03, Vol.12 (1), p.4355-4355, Article 4355

2022

Volltextzugriff (PDF)

Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma

Cancer science, 2017-05, Vol.108 (5), p.1022-1031

2017

Volltextzugriff (PDF)

Malignant melanoma treatment using brachytherapy: Two case reports and 15 case series

Journal of dermatology, 2023-01, Vol.50 (1), p.94-97

2023

Volltextzugriff (PDF)

Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy

Oncotarget, 2016-11, Vol.7 (47), p.77404-77415

2016

Volltextzugriff (PDF)

Safety and efficacy of nivolumab in Japanese patients with malignant melanoma: An interim analysis of a postmarketing surveillance

Journal of dermatology, 2018-04, Vol.45 (4), p.408-415

2018

Volltextzugriff (PDF)

Erlotinib-related skin toxicities: Treatment strategies in patients with metastatic non-small cell lung cancer

Journal of the American Academy of Dermatology, 2013-09, Vol.69 (3), p.463-472

2013

Volltextzugriff (PDF)

Real‐world efficacy and safety data for dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation‐positive advanced melanoma

Journal of dermatology, 2020-03, Vol.47 (3), p.257-264

2020

Volltextzugriff (PDF)

Efficacy and safety of nivolumab in Japanese patients with previously untreated advanced melanoma: A phase II study

Cancer science, 2017-06, Vol.108 (6), p.1223-1230

2017

Volltextzugriff (PDF)

Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post‐marketing surveillance

Journal of dermatology, 2022-09, Vol.49 (9), p.862-871

2022

Volltextzugriff (PDF)

Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update

International journal of clinical oncology, 2008-02, Vol.13 (1), p.33-41

2008

Volltextzugriff (PDF)

Real‐world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance

Journal of dermatology, 2020-08, Vol.47 (8), p.834-848

2020

Volltextzugriff (PDF)

RB1 gene mutations are a distinct predictive factor in Merkel cell carcinoma

Pathology international, 2021-05, Vol.71 (5), p.337-347

2021

Volltextzugriff (PDF)

Clinical characteristics associated with BRAF , NRAS and KIT mutations in Japanese melanoma patients

Journal of dermatological science, 2015-10, Vol.80 (1), p.33-37

2015

Volltextzugriff (PDF)

Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial

BMC cancer, 2023-05, Vol.23 (1), p.401-401, Article 401

2023

Volltextzugriff (PDF)

1 – 25 von 747

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(543)
Mit Volltextzugriff
(598)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Targeted Therapy and Immunotherapy for Melanoma in Japan

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab

The Development of a Skin Cancer Classification System for Pigmented Skin Lesions Using Deep Learning

Merkel cell carcinoma: a review of clinical management with focus on Asian patients

A review of the AJCC melanoma staging system in the TNM classification (eighth edition)

Epidemiology of skin cancer based on Japan's National Cancer Registry 2016–2017

Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice

Prognostic factor analysis of definitive radiotherapy using intensity-modulated radiation therapy and volumetric modulated arc therapy with boluses for scalp angiosarcomas

Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma

Malignant melanoma treatment using brachytherapy: Two case reports and 15 case series

Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy

Safety and efficacy of nivolumab in Japanese patients with malignant melanoma: An interim analysis of a postmarketing surveillance

Erlotinib-related skin toxicities: Treatment strategies in patients with metastatic non-small cell lung cancer

Real‐world efficacy and safety data for dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation‐positive advanced melanoma

Efficacy and safety of nivolumab in Japanese patients with previously untreated advanced melanoma: A phase II study

Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post‐marketing surveillance

Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients

Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update

Real‐world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance

RB1 gene mutations are a distinct predictive factor in Merkel cell carcinoma

Clinical characteristics associated with BRAF , NRAS and KIT mutations in Japanese melanoma patients

Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial

Suchergebnisse filtern